C-reactive protein (CRP): more than just an innocent bystander?

Authors: Paraskevas, Kosmas I.1; Mikhailidis, Dimitri P.1

Source: Current Medical Research and Opinion, Volume 24, Number 1, January 2008 , pp. 75-78(4)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

This editorial discusses whether measuring C-reactive protein (CRP) levels can be used as a predictor of vascular risk. The agents that reduce CRP levels and the evidence for a possible causative role of CRP in the pathogenesis of coronary events and atherosclerosis are also considered. There is a need to further elucidate the role of CRP, as well as the clinical relevance, if any, of CRP-lowering agents.

Keywords: ATHEROSCLEROSIS; C-REACTIVE PROTEIN; INFLAMMATION; PROGNOSTIC MARKER

Document Type: Editorial

DOI: 10.1185/030079908X253654

Affiliations: 1: Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital and Royal Free University College Medical School, University College London (University of London), London, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A